Cargando…
Digital-Droplet PCR for Quantification of CD19-Directed CAR T-Cells
CD19-directed CAR-T-cells (CD19-CAR) have demonstrated remarkable clinical results in patients suffering from refractory or relapsed lymphoma and acute lymphoblastic leukemia. In order to further optimize follow-up, to explain treatment failure, and to control adverse events biomarkers for monitorin...
Autores principales: | Mika, Thomas, Maghnouj, Abdelouahid, Klein-Scory, Susanne, Ladigan-Badura, Swetlana, Baraniskin, Alexander, Thomson, Julia, Hasenkamp, Justin, Hahn, Stephan A., Wulf, Gerald, Schroers, Roland |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243121/ https://www.ncbi.nlm.nih.gov/pubmed/32500079 http://dx.doi.org/10.3389/fmolb.2020.00084 |
Ejemplares similares
-
Altered T-Lymphocyte Biology Following High-Dose Melphalan and Autologous Stem Cell Transplantation With Implications for Adoptive T-Cell Therapy
por: Mika, Thomas, et al.
Publicado: (2020) -
Liquid biopsy based HER2 amplification status in gastric cancer patients indicates clinical response
por: Klein-Scory, Susanne, et al.
Publicado: (2023) -
Quantification of cell-free DNAfor the analysis of CD19-CAR-T cells during lymphoma treatment
por: Mika, Thomas, et al.
Publicado: (2021) -
Evolution of RAS Mutational Status in Liquid Biopsies During First-Line Chemotherapy for Metastatic Colorectal Cancer
por: Klein-Scory, Susanne, et al.
Publicado: (2020) -
Cytotoxicity of CD19-CAR-NK92 cells is primarily mediated via perforin/granzyme pathway
por: Althaus, Jonas, et al.
Publicado: (2023)